nonalcoholic steatohepatitis Archives

Lanifibranor, a first-in-class pan-peroxisome proliferator-activated receptor (PPAR) agonist, has shown promise in the treatment of nonalcoholic steatohepatitis (NASH), an aggressive

Health News

Coffee Could Be the Secret Weapon Against NAFLD

06/04/2021 biliary disease, Cirrhosis, Diabetes Mellitus, diabetes mellitus type 2, diabetes mellitus type ii, exercise, gallbladder disease, hypertension, Liver Disease, liver fibrosis, Metabolic Syndrome, morbid obesity, nafld, nash (nonalcoholic steatohepatitis), nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, obese, Obesity, physical act, portal hypertension, Sleep Apnea, Sleep Disorder, type 2 diabetes

Treatment of obesity through exercise and diet is unquestionably the foundation of care for patients with nonalcoholic fatty liver disease

Erwotex.net

Novel Drug Lanifibranor Promising for NASH

Coffee Could Be the Secret Weapon Against NAFLD